 "Lupin to acquire French pharma company Medisol for around Rs 160 crore")
The company has entered into a definitive agreement to acquire the entire share capital of Medisol, subject to approval from the French Ministry of Economy and Finance, Lupin said in a regulatory filing. Founded in 2011, Medisol specialises in generics injectable products.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)